Correlation Between HCW Biologics and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and Neurocrine Biosciences, you can compare the effects of market volatilities on HCW Biologics and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Neurocrine Biosciences.

Diversification Opportunities for HCW Biologics and Neurocrine Biosciences

-0.07

Correlation Coefficient

HCW Biologics  Neurocrine Biosciences

Good diversification

The 3 months correlation between HCW and Neurocrine is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of HCW Biologics i.e., HCW Biologics and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between HCW Biologics and Neurocrine Biosciences

Given the investment horizon of 90 days HCW Biologics is expected to under-perform the Neurocrine Biosciences. In addition to that, HCW Biologics is 3.03 times more volatile than Neurocrine Biosciences. It trades about -0.09 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.02 per unit of volatility. If you would invest  14,200  in Neurocrine Biosciences on August 13, 2024 and sell it today you would lose (1,483) from holding Neurocrine Biosciences or give up 10.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

HCW Biologics  vs.  Neurocrine Biosciences

HCW Biologics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HCW Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Neurocrine Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with HCW Biologics and Neurocrine Biosciences

The main advantage of trading using opposite HCW Biologics and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind HCW Biologics and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.